Teriparatide Dosage Guide
Complete guide to Teriparatide dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
20 mcg
Route
subcutaneous
Frequency
1x daily
Cycle Length
52-104 weeks
Reconstitution
Vial Size
1 mg
BAC Water
3.0 ml
Concentration
333.333 mcg/ml
Detailed Dosage Information
20mcg subcutaneously once daily. Maximum treatment duration of 2 years due to theoretical osteosarcoma risk from rat studies.
Administration Method
Subcutaneous injection in thigh or abdomen once daily. Delivered via multi-dose pen. Should sit or lie down after injection due to orthostatic hypotension risk.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 333.333 mcg/ml
Volume to inject: 0.06 ml
Syringe units (U-100): 6.0 units
Pre-filled with Teriparatide defaults. Adjust values as needed.
Side Effects to Monitor
Orthostatic hypotension, leg cramps, nausea, dizziness, headache, and injection site reactions. Transient hypercalcemia possible.
Safety Considerations & Risks
Boxed warning for osteosarcoma risk (seen in rat studies at high doses). Contraindicated in Paget's disease, unexplained elevated ALP, prior bone radiation, or bone metastases.